Biosfer Teslab, a spin-off generated from the Metabolimics Platform research studies.

Posted on Feb 3, 2014 in Education, Research

Roger Mallol and Núria Amigó, PhD students from de Metabolomics Platform, set up the spin-off Biosfer Teslab, a company that produces an advanced lipoprotein test to predict cardiovascular diseases.

The company Biosfer Teslab won the price ReusEmpresa  last November 2013.

http://www.reusdirecte.cat/cat/notices/2013/11/l_empresa_biosfer_teslab_guanya_els_x_premis_reusempresa_que_es_lliuraran_el_21_de_novembre_33836.php

http://wwwa.urv.cat/noticies/diari_digital/cgi/principal.pl?fitxer=noticies/noticia015400.htm